Vect-Horus is leveraging its technology platform to build a pipeline of vector-payload candidates, aiming for indications with strong unmet medical needs such as neurodegenerative diseases, or pathological conditions, including genetic disorders or cancers. These candidates are developed either as proprietary molecules or in collaboration with pharmaceutical and biotechnology companies. The Company has currently the following ongoing collaboration agreements, some of which are still undisclosed.
